Which drugs does patent 8,377,952 protect, and when does it expire?
Patent 8,377,952 protects KALETRA and is included in one NDA. There have been two Paragraph IV challenges on Kaletra.
Protection for KALETRA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty-eight patent family members in twenty-five countries.